At the 2026 American Academy of Dermatology meeting, Reid Waldman, M.D., shared data showing that Veradermics’ ...

Spironolactone is not a new medication, but it has been fairly slow to catch on as a treatment for acne. In an interview with Managed Healthcare Executive (MHE), John S. Barbieri, ...

Treatment speed and patient perception are emerging as key factors in managing pattern hair loss, especially as many patients ...

Patients across the United States are skipping or postponing medical appointments because they cannot get a clear answer ...

Vitiligo is a chronic autoimmune disease characterized by the destruction of melanocytes, the cells responsible for producing ...

Work requirements and new redetermination requirements could slash the number of people covered by Medicaid by more than 55% ...

Get clear answers to the biggest questions health leaders are asking about the Great Healthcare Plan. This FAQ breaks down ...

Emerging insights, future therapies, and an interview with Eric T. Rush, M.D. This content is a production of Managed Healthcare Executive; distribution of this Focus on Disease supplement is ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

Findings from a study published March 20 in JAMA Health Forum showed that higher income is linked to better healthcare access ...

EHR-driven identification and outreach target older adults at high risk for cognitive impairment, addressing evidence that most mild cognitive impairment remains undetected in primary care. Community ...

Oral Wegovy becomes the first GLP-1 pill indicated for obesity, distinct from Rybelsus, which remains positioned for type 2 diabetes treatment. Daily administration improves acceptability for ...